This statistic depicts the percentage of orphan and oncology drugs released in Canada and select other developed countries that were new active substances (NAS) from 2015 to 2022. According to the data, in 2022, 56 percent of approved new active substances received an orphan drug designation.
Share of orphan or oncology drugs among approved new active substances (NAS) in select developed countries from 2015 to 2022
Includes drugs launched in: Canada, Belgium, France, Germany, Italy, the Netherlands, Norway, Spain, Sweden, the
United Kingdom, and the United States.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
PMPRB. (May 30, 2024). Share of orphan or oncology drugs among approved new active substances (NAS) in select developed countries from 2015 to 2022 [Graph]. In Statista. Retrieved November 21, 2024, from https://www.statista.com/statistics/892120/new-active-substances-global-orphan-and-oncology-drugs/
PMPRB. "Share of orphan or oncology drugs among approved new active substances (NAS) in select developed countries from 2015 to 2022." Chart. May 30, 2024. Statista. Accessed November 21, 2024. https://www.statista.com/statistics/892120/new-active-substances-global-orphan-and-oncology-drugs/
PMPRB. (2024). Share of orphan or oncology drugs among approved new active substances (NAS) in select developed countries from 2015 to 2022. Statista. Statista Inc.. Accessed: November 21, 2024. https://www.statista.com/statistics/892120/new-active-substances-global-orphan-and-oncology-drugs/
PMPRB. "Share of Orphan or Oncology Drugs among Approved New Active Substances (Nas) in Select Developed Countries from 2015 to 2022." Statista, Statista Inc., 30 May 2024, https://www.statista.com/statistics/892120/new-active-substances-global-orphan-and-oncology-drugs/
PMPRB, Share of orphan or oncology drugs among approved new active substances (NAS) in select developed countries from 2015 to 2022 Statista, https://www.statista.com/statistics/892120/new-active-substances-global-orphan-and-oncology-drugs/ (last visited November 21, 2024)
Share of orphan or oncology drugs among approved new active substances (NAS) in select developed countries from 2015 to 2022 [Graph], PMPRB, May 30, 2024. [Online]. Available: https://www.statista.com/statistics/892120/new-active-substances-global-orphan-and-oncology-drugs/
